FDA Import Refusal 1FX-4666446-1/50002/1 — CAPLIN POINT

CAPLIN POINT — FEI 3023419653

The FDA refused shipment 1FX-4666446-1/50002/1 from CAPLIN POINT (Guatemala) on July 1, 2026. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.